In the latest trading session,, 0.72 million Novavax, Inc (NASDAQ:NVAX) shares changed hands as the company’s beta touched 2.93. With the company’s most recent per share price at $6.21 changed hands at -$0.1 or -1.58% at last look, the market valuation stands at $998.85M. NVAX’s current price is a discount, trading about -284.22% off its 52-week high of $23.86. The share price had its 52-week low at $3.81, which suggests the last value was 38.65% up since then. When we look at Novavax, Inc’s average trading volume, we note the 10-day average is 5.78 million shares, with the 3-month average coming to 4.33 million.
Analysts gave the Novavax, Inc (NVAX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.14. If we narrow down to specifics, the data shows that 0 out of 16 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 6 recommended NVAX as a Hold, 10 felt it is a Buy and 0 rated the stock as Underweight.
Novavax, Inc (NASDAQ:NVAX) trade information
Instantly NVAX was in red as seen in intraday trades today. With action 3.85%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -22.76%, with the 5-day performance at 3.85% in the green. However, in the 30-day time frame, Novavax, Inc (NASDAQ:NVAX) is -21.59% down. Looking at the short shares, we see there were 37.55 million shares sold at short interest cover period of 7.71 days.
The consensus price target for the stock as assigned by Wall Street analysts is 22, meaning bulls need an upside of 71.77% from its recent market value. According to analyst projections, NVAX’s forecast low is 14 with 25 as the target high. To hit the forecast high, the stock’s price needs a -302.58% plunge from its current level, while the stock would need to soar -125.44% for it to hit the projected low.
Novavax, Inc (NVAX) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 25.88%. The 2025 estimates are for Novavax, Inc earnings to increase by 123.69%.
Novavax, Inc (NASDAQ:NVAX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 8.80% of Novavax, Inc shares while 60.21% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 66.02%. There are 60.21% institutions holding the Novavax, Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 10.0599% of the shares, roughly 14.08 million NVAX shares worth $178.19 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.984% or 11.85 million shares worth $149.98 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 4.79 shares estimated at $30.09 million under it, the former controlled 2.98% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.49% of the shares, roughly 4.0 shares worth around $25.14 million.
